Results 191 to 200 of about 513,484 (358)

Combining immunotherapy with radiation therapy in thoracic oncology [PDF]

open access: yes, 2018
Badiyan, Shahed N   +9 more
core   +1 more source

A Promising Point‐of‐Care Testing Strategy: Ultrasmooth Gold Nanogroove Arrays Biosensor Combined with Initial Rate Analysis

open access: yesAdvanced Science, EarlyView.
This work reports a nanoplasmonic biosensing platform with exceptional surface sensitivity (0.618 nm nm−1, Δn = 0.117 nmol) and narrow linewidth (≈20 nm) under normal incidence. By integrating a miscellaneous‐protein strategy with initial rate analysis (IRA), this sensor can detect 1 ng mL−1 of AFP in serum with a broad linear range (1–104 ng mL−1 ...
Yi Liu   +6 more
wiley   +1 more source

Uncertainty estimation for dosimetry in radiation oncology. [PDF]

open access: yesPhys Imaging Radiat Oncol
Lechner W, Palmans H.
europepmc   +1 more source

A Phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207) [PDF]

open access: bronze, 2000
Laurie E. Gaspar   +5 more
openalex   +1 more source

Hexokinase‐2 as a Therapeutic Target: Alleviating Herpes Simplex Keratitis Through Metabolic Reprogramming

open access: yesAdvanced Science, EarlyView.
Herpes Simplex Virus Type 1 (HSV‐1) infection triggers metabolic reprogramming in corneal cells, shifting from mitochondrial respiration to aerobic glycolysis with marked upregulation of Hexokinase‐2 (HK2). This study identifies HK2 as a therapeutic target: inhibiting HK2 with lonidamine significantly reduces viral replication and promotes corneal ...
Dan Jiang   +9 more
wiley   +1 more source

Current and Future Developments in Radiation Oncology Approach for Rhabdomyosarcoma. [PDF]

open access: yesCancers (Basel)
Dávila Fajardo R   +4 more
europepmc   +1 more source

Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: Results of 3 consecutive radiation therapy oncology group (RTOG) trials

open access: bronze, 1992
J.R. Simpson   +10 more
openalex   +1 more source

STK25 Loss Augments Anti‐PD‐1 Therapy Efficacy by Regulating PD‐L1 Stability in Colorectal Cancer

open access: yesAdvanced Science, EarlyView.
This study demonstrates that STK25 depletion facilitates CRC immune escape through the inhibition of PD‐L1 Ser283 phosphorylation‐mediated ubiquitination, and promotes tumor growth. Furthermore, these findings identify STK25 as a potential therapeutic target to trigger antitumor immunity and promote immunotherapy efficacy. Abstract Tumor immune evasion
Xiaowen Qiao   +20 more
wiley   +1 more source

Home - About - Disclaimer - Privacy